Viman MD
ActiveSummary
Viman MD has been active since 2018 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €30,952 and a net result of €457,986. Equity is growing by ~10.5% per year across the filed fiscal years. Its solvency ranks better than 14% of 17112 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency36▼-30
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2,000 at 30 days acceptable
Liquidity short (current ratio 0.87 against 1.36 in 2024; short-term debt: 89.3% and cash: 11.9% of total assets), and 89.3% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
10.7%
Return on assets
158.2%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 17112 sector peers (2025).
NBB · sector comparisonPosition among 17112 sector peers
Solvency
better than 14%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-07-2026, 28 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
28 d early
2024
21 d early
2023
26 d early
2022
26 d early
2021
2 d early
2020
11 d early
2019
21 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 19 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 6 July (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
01-10-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Turnover
€470,028
EBIT margin
26.9%
Net result
€457,986▼ 9.8%
2024 · €507,652
Working capital
-€33,740
2024 · €55,190
Trend over the years
In euros
In per cent
Ratio
In euros
No line ticked in this group.
In per cent
No line ticked in this group.
Ratio
No line ticked in this group.
Untick a line to hide it. Point at a year (or use the arrow keys on the chart) for the exact figures; the table below gives them all.Sector: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Turnover€470,028
Operating result€126,453▲ 32.4%€261,792▲ 107%€628,429▲ 140%€686,602▲ 9.3%€656,548▼ 4.4%
Net result€94,460within the sector's middle half▲ 42.2%€193,571above the sector's middle half▲ 105%€463,914above the sector's middle half▲ 140%€507,652above the sector's middle half▲ 9.4%€457,986above the sector's middle half▼ 9.8%
EBIT margin26.9%
Equity€95,625within the sector's middle half▲ 34.2%€104,784within the sector's middle half▲ 9.6%€104,784within the sector's middle half=€104,784within the sector's middle half=€30,952below the sector's middle half▼ 70.5%
Total assets€214,769within the sector's middle half▲ 34.4%€254,665within the sector's middle half▲ 18.6%€278,793within the sector's middle half▲ 9.5%€256,550within the sector's middle half▼ 8.0%€289,533within the sector's middle half▲ 12.9%
Debt€119,144▲ 34.5%€149,881▲ 25.8%€174,009▲ 16.1%€151,766▼ 12.8%€258,580▲ 70.4%
Working capital€81,090within the sector's middle half▲ 48.3%€82,083within the sector's middle half▲ 1.2%€55,717within the sector's middle half▼ 32.1%€55,190within the sector's middle half▼ 0.9%-€33,740below the sector's middle half
Solvency44.5%within the sector's middle half▼ 0.1pp41.1%within the sector's middle half▼ 3.4pp37.6%within the sector's middle half▼ 3.6pp40.8%within the sector's middle half▲ 3.3pp10.7%below the sector's middle half▼ 30.2pp
Current ratio1.81within the sector's middle half▼ 0.061.58within the sector's middle half▼ 0.221.32below the sector's middle half▼ 0.261.36below the sector's middle half▲ 0.040.87below the sector's middle half▼ 0.49
Return on assets (ROA)44.0%above the sector's middle half▲ 2.4pp76.0%above the sector's middle half▲ 32.0pp166.4%above the sector's middle half▲ 90.4pp197.9%above the sector's middle half▲ 31.5pp158.2%above the sector's middle half▼ 39.7pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 4% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €289,533
Fixed assets
€64,692 ▲ 30.4%
Current assets
€224,841 ▲ 8.6%
Equity and liabilities €289,533
Equity
€30,952 ▼ 70.5%
Debt
€258,580 ▲ 70.4%
Debt's share of the balance-sheet total rises from 59.2% to 89.3%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€668,835▼
2024 · €704,002
Cash flow
€470,273▼
2024 · €525,052
Debt to equity
8.35▲
2024 · 1.45
Interest coverage
56.51▼
2024 · 87.93
Debt ≤ 1 year
€258,580▲
2024 · €151,766
Income taxes
€186,736▲
2024 · €171,409
A ratio outside any meaningful range has been withheld (balance sheet total €289,533, equity €30,952).
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 6,713 companies that looked in July 2024 the way this one looks now, 1.8% went bankrupt within 24 months and 96% are still going.
- Micro
- 5 to 10 years old
- solvency 10 to 30%
- a profit of 5% of the balance sheet or more
1.8%
went bankrupt
2.2%
stopped otherwise
96%
still going
A further 0.1% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,341 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 6,713 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Turnover70 | €470,028 | - | - | - | - | - |
| Non-recurring operating income76A | €0 | - | - | - | €12,759 | - |
| Goods, raw materials, services and sundry goods60/61 | €338,638 | - | - | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €11,074 | €10,563 | €13,677 | €17,400 | €12,287 | ▼ 29.4% |
| Other operating charges640/8 | €1,125 | €1,083 | €1,250 | €1,376 | €1,750 | ▲ 27.2% |
| Non-recurring operating charges66A | - | €563 | €3,768 | €1,124 | €0 | ▼ 100% |
| Gross operating margin9900 | €138,652 | €274,001 | €647,124 | €706,502 | €670,585 | ▼ 5.1% |
| Operating profit (loss)9901 | €126,453 | €261,792 | €628,429 | €686,602 | €656,548 | ▼ 4.4% |
| Financial income75/76B | €0 | €213 | €737 | €466 | €9 | ▼ 98.1% |
| Recurring financial income75 | €0 | €213 | €737 | €466 | €9 | ▼ 98.1% |
| Financial charges65/66B | €1,143 | €519 | €3,595 | €8,006 | €11,836 | ▲ 47.8% |
| Recurring financial charges65 | €1,143 | €519 | €3,595 | €8,006 | €11,836 | ▲ 47.8% |
| Profit (loss) for the period before taxes9903 | €125,310 | €261,486 | €625,571 | €679,062 | €644,721 | ▼ 5.1% |
| Income taxes67/77 | €30,850 | €67,915 | €161,657 | €171,409 | €186,736 | ▲ 8.9% |
| Profit (loss) for the period9904 | €94,460 | €193,571 | €463,914 | €507,652 | €457,986 | ▼ 9.8% |
| Profit (loss) for the period to be appropriated9905 | €94,460 | €193,571 | €463,914 | €507,652 | €457,986 | ▼ 9.8% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €214,769 | €254,665 | €278,793 | €256,550 | €289,533 | ▲ 12.9% |
| Fixed assets21/28 | €33,445 | €32,114 | €50,419 | €49,594 | €64,692 | ▲ 30.4% |
| Tangible fixed assets22/27 | €33,445 | €32,114 | €50,419 | €49,594 | €64,692 | ▲ 30.4% |
| Plant, machinery and equipment23 | €2,032 | €4,516 | €6,507 | €9,333 | €10,585 | ▲ 13.4% |
| Furniture and vehicles24 | €31,413 | €27,598 | €43,913 | €40,261 | €54,107 | ▲ 34.4% |
| Current assets29/58 | €181,324 | €222,552 | €228,374 | €206,956 | €224,841 | ▲ 8.6% |
| Amounts receivable within one year40/41 | €173,886 | €170,708 | €205,330 | €194,373 | €1,196 | ▼ 99.4% |
| Trade receivables40 | €173,886 | €151,496 | €183,389 | €194,373 | €1,196 | ▼ 99.4% |
| Other amounts receivable41 | - | €19,213 | €21,942 | €0 | - | - |
| Cash at bank and in hand54/58 | €4,973 | €46,959 | €19,732 | €8,304 | €34,324 | ▲ 313% |
| Deferred charges and accrued income490/1 | €2,465 | €4,885 | €3,312 | €4,278 | €189,321 | ▲ 4,325% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €214,769 | €254,665 | €278,793 | €256,550 | €289,533 | ▲ 12.9% |
| Equity10/15 | €95,625 | €104,784 | €104,784 | €104,784 | €30,952 | ▼ 70.5% |
| Contributions10/11 | €18,600 | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €76,000 | €85,000 | €85,000 | €85,000 | €9,000 | ▼ 89.4% |
| Distributable reserves133 | €76,000 | €85,000 | €85,000 | €85,000 | €9,000 | ▼ 89.4% |
| Profit (loss) carried forward14 | €1,025 | €1,184 | €1,184 | €1,184 | €3,352 | ▲ 183% |
| Amounts payable17/49 | €119,144 | €149,881 | €174,009 | €151,766 | €258,580 | ▲ 70.4% |
| Amounts payable after more than one year17 | €17,384 | €9,412 | €1,352 | €0 | - | - |
| Financial debts170/4 | €17,384 | €9,412 | €1,352 | €0 | - | - |
| Amounts payable within one year42/48 | €100,234 | €140,469 | €172,657 | €151,766 | €258,580 | ▲ 70.4% |
| Current portion of amounts payable after more than one year42 | €7,885 | €7,972 | €8,053 | €1,352 | €0 | ▼ 100% |
| Financial debts43 | - | - | - | - | €189 | - |
| Credit institutions430/8 | - | - | - | - | €189 | - |
| Trade debts44 | €1,024 | €7,947 | €13,909 | €4,471 | €12,729 | ▲ 185% |
| Suppliers440/4 | €1,024 | €7,947 | €13,909 | €4,471 | €12,729 | ▲ 185% |
| Taxes, remuneration and social security45 | €22,650 | €7,050 | €20,775 | €28,809 | €51,899 | ▲ 80.1% |
| Taxes450/3 | €22,650 | €7,050 | €20,775 | €28,809 | €51,899 | ▲ 80.1% |
| Other amounts payable47/48 | €68,675 | €117,500 | €129,920 | €117,134 | €193,763 | ▲ 65.4% |
| Accrued charges and deferred income492/3 | €1,526 | €0 | - | - | - | - |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €94,460 | €193,571 | €463,914 | €507,652 | €457,986 | ▼ 9.8% |
| + Depreciation and write-downs630 | €11,074 | €10,563 | €13,677 | €17,400 | €12,287 | ▼ 29.4% |
| Operating cash flow (approximation) | €105,534 | €204,134 | €477,591 | €525,052 | €470,273 | ▼ 10.4% |
| Investment in fixed assets (approximation) | - | -€9,232 | -€31,983 | -€16,575 | -€27,385 | ▼ 65.2% |
| Change in cash | - | €41,986 | -€27,227 | -€11,427 | €26,020 | ▲ 328% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
03-07
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
10-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2018net €507,652 ▲9.4%
Operating result €686,602, net result €507,652, both a record.
05-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
05-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €100,000Eq €104,784 ▲9.6%
3 profitable years in a row build equity to €104,784.
29-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
20-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Back to profitnet €66,406
Net result €66,406 after one loss-making year.
10-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial
Weakest financial yearnet -€3,504
Net result drops to -€3,504, the lowest in the series; recovery starts the following year.
26-06
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
No directors read yet: 0 of 3 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Izegem · 1 establishment unit since 2018
Ground area
2,641 m²
Building footprint
352 m²
Volume, LiDAR
1,557 m³
Parcel 36008C0483/00G000, Flanders · tallest building 7.9 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
VIMAN MD
since 20182.281.133.063
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 36008C0483/00G000 | Flanders | 2,641 m² | 1 · 351 m² | 7.9 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
TROCARDIO
BE 0791.556.721
Seraing · Eq €30,964
DR. WAJER, GYNAECOLOOG
BE 0846.812.671
Vilvoorde · Eq €30,972
Dr. B. Persoons
BE 0750.632.025
Westerlo · Eq €30,925
Bloedserieus
BE 1026.949.787
Kinrooi · Eq €30,882
BE UNIQUE ESTHETIC CLINIC
BE 0778.398.868
Kapellen · Eq €30,795
Of 16,625 companies in this sector we hold annual accounts for 7,989. 4,085 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company details
Identification
Legal formPrivate limited company
Founded26-10-2018
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0712637422
Also
9925:BE0712637422
Registered
10-07-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 1 October 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.